Nagoya Protocol on Access and Benefit Sharing (ABS) EU ABS Regulation – Training workshop for scientists

Berlin (DE)

The EU ABS Regulation training workshop aims at providing the participants with knowledge about their obligations under the EU ABS Regulation and what they practically imply for their everyday work. In the first part of the workshop, the new legal framework will be explained, providing insight into the main provisions of the EU ABS Regulation. In the second part of the workshop, participants will have a chance to put the knowledge gained into practice through interactive case studies, based on real-life examples and realistic scenarios.
Contact: eCOAST/European commission

23.11.2015 - 24.11.2015

European Business Development Conference 2015

Antwerpen (B)

The European Business Development Conference (EBDC) is an annual event that aims to bring together business development executives from international pharmaceutical corporations and European biotech companies, with representatives from private equity and venture capital companies. This years’ motto is: Transborder – Transaction – Translation. The conference provides an exclusive platform to learn, network and discuss collaboration opportunities. Excellent speakers inspire your future business and opinion leaders facilitate your interactions.
Contact: Matthias Bach, BIO Deutschland
Phone: +49-30-726-25-136

23.11.2015 - 24.11.2015

EuroPLX 59 – European Pharma License Exchange

Athens (GR)

The partnering scope ranges from innovative to generic, from early stage candidates to approved, prescription or OTC drugs, medical devices and companion diagnostics. Delegates determine the focus, displayed and updated hourly on Internet as soon as sufficient data are submitted.
Contact: Dr. Norbert Rau, RauCon

25.11.2015 - 26.11.2015

Global Bioeconomy Summit 2015


Recent years have seen significant worldwide investment in the bioeconomy, in both political and economic terms. Bioeconomy advisory bodies and agencies have been nominated in many of the G7 and G20 countries. However, a policy focused on domestic territories and players will hardly unleash the full potential of these public and private investments. Successful policy measures have to take account of the impact of global value-chains and markets. Due to a lack in formalised international discussion platforms, bioeconomy policy making has remained somewhat fragmented and detached from other important policy areas sharing the same goals, such as sustainability or green growth.
Who should attend?
The GBS2015 addresses government officials, advisory bodies, associations, international organisations, NGOs, scientists and other stakeholders with a political function. The highly interactive format will thus cover strategy, governance and policy design.
Contact: Dr. Patrick Dieckhoff, Geschäftsstelle Bioökonomierat
Phone: +49 30 4677 6743

30.11.2015 - 02.12.2015

6th World Congress on Biotechnology

Hyderabad (IN)

The Congress is the global forum basing on the Theme: Biotechnology: Meeting the Needs of a Changing World. It aims to promote the international and national exchange of ideas, promote collaborative research network among academia and industry. Besides this dissemination of knowledge this world congress brings an opportunity for professionals to build up a scientific and professional network as well. Young researchers, postdoctoral researchers, graduate students and other professionals are warmly welcome to the Workshop entitled “NIH Research Resources in Biotechnology”.
Contact: Rajesh K. Guru, OMICS Group

01.12.2015 - 02.12.2015

BioFIT 2015

Strasbourg (F)

leading partnering event in Europe for open innovation, technology transfer and collaborative research in the field of Life Sciences
Contact: Marion Sigier, eurosante/Nutrition Sante Longevte

5th Munich Biomarker Conference


01.12.2015 - 02.12.2015

5th Munich Biomarker Conference

Munich (GER)

The Munich Biomarker Conference brings together international experts from biotech and pharma industry with scientists and physicians. The programme covers all stages of biomarker development, from basic research to personalized treatment of patients. A focus lies on the translation of academic research findings into industry-driven drug development. A second core topic is the realization of individualized treatment in the standard of care. How can clinical processes, data management and reimbursement be adjusted to unleash the potential of personalized medicine? Strategies to overcome current limitations and possible solutions are discussed.
Contact: Dr. Almut Windhager, BioM Biotech Cluster Development GmbH

09.12.2015 - 10.12.2015

The 2015 Biopolymer Summit

London (UK)

The Summit will bring together key industry experts to discuss the latest strategies and methods to overcome current challenges, and maximise the opportunities. The conference will address how the industry will evolve, current trends, how to respond to the changes of the market and the growing demand from end users. Over the two days, the event will bring insights into end users expectations and environmental approaches, amongst others. Attendees will also be able to interact and discuss regional markets, while developing future business opportunity in biopolymers.
Contact: Mohammad Ahsan, ACI

18.02.2016 - 19.02.2016

6th Crossroads in Biology


CIB Symposium is organized entirely by graduate students and aims at bringing together
leading scientists from diverse areas of biological research in an interactive environment.
They have already received confirmation of attendance from 10 speakers from
Europe, USA and Australia including Prof. Stefan Hell (Nobel Prize in Chemistry, 2014).
Contact: Universität Köln

06.03.2016 - 09.03.2016

ECO-BIO 2016

Rotterdam (NL)

Challenges in building a Sustainable Bioeconomy – This conference will be a first of its kind and will highlight the emergence of the research and innovation field, where we are today and what needs to be done to develop an economically feasible, safe, sustainable, and ecologically friendly biobased future. The conference will be a platform to further the discussions on this highly societal relevant topic.
Contact: BE-Basic Foundation/Elsevier

07.03.2016 - 08.03.2016

EuroPLX 60 – European Pharma License Exchange

Barcelona (ES)

The partnering scope ranges from innovative to generic, from early stage candidates to approved, prescription or OTC drugs, medical devices and companion diagnostics. Delegates determine the focus, displayed and updated hourly on Internet as soon as sufficient data are submitted.
Contact: Dr. Norbert Rau, RauCon

© 2007-2015 BIOCOM


Current issue

All issues


All videos

Product of the week


Stock list

All quotes


  • NEOVACS (F)0.75 EUR8.70%
  • THROMBOGENICS (B)4.16 EUR8.33%


  • BAVARIAN NORDIC (D)35.60 EUR-8.48%
  • IMMUPHARMA (UK)37.00 GBP-6.92%


  • CHRONTECH PHARMA (S)0.36 SEK3500.0%
  • THROMBOGENICS (B)4.16 EUR46.0%
  • OREXO (S)61.75 SEK24.2%


  • TRANSGENE (F)2.80 EUR-42.0%
  • GALAPAGOS (B)39.16 EUR-23.8%


  • KARO BIO (S)44.10 SEK4693.5%
  • CHRONTECH PHARMA (S)0.36 SEK350.0%
  • GALAPAGOS (B)39.16 EUR231.9%


  • NEOVACS (F)0.75 EUR-78.5%
  • BIOTEST (D)18.80 EUR-75.4%

No liability assumed, Date: 05.10.2015


All Events